Skip to content
Date posted: 12 December 2012
A new website for a collaborative centre which provides information on injecting drug use (IDU) in Australia is now available.
The Centre for Research Excellence into Injecting Drug Use (CREIDU) officially opened in 2011, but has not had its own online presence until recently.
The Centre is a collaboration between the Burnet Institute, the National Drug and Alcohol Research Centre, the Kirby Institute, Turning Point Alcohol and Drug Centre, the National Drug Research Institute, the University of Queensland, the Australian National University, the University of Melbourne, Anex, Harm Reduction Victoria and Hepatitis Victoria.
CREIDU's vision is to improve the health of people who inject drugs by generating new knowledge and effectively translating this into policy and practice. The Centre brings together researchers, policy-makers and community-sector representatives working in the fields of alcohol and illicit drugs, blood-borne virus transmission, justice health, mental health, and policy research.
Burnet's Associate Professor Margaret Hellard, lead investigator with CREIDU, says 'The centre's focus is to increase our knowledge about IDU and its health and social effects, so ultimately we can identify ways to prevent or reduce the severity of health and social outcomes through policy and practice.'
'What also makes this NHMRC-funded project unique is that we also bring together experts from IDU-related areas such as blood-borne virus, epidemiology and treatment (particularly hepatitis C), overdose prevention, justice health and psychiatric health.'
CREIDU also provides seed-funding for research and other projects on an annual basis. Recent events of interest on the website have included:
The CREIDU project is funded by the National Health and Medical Research Council (NHMRC).
Source: Burnet Institute, Centre for Research Excellence into Injecting Drug Use, Western Australian Network of Alcohol and other Drug Agencies
Centre for Research Excellence into Injecting Drug Use
Ph: (03) 8506 2379